A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy

ConclusionAlthough we achieved 100% technical success in intrathecal nusinersen administration, our practices evolved during the course of this study. As a result of our early experience we developed an algorithm to assist in promoting safe and effective nusinersen administration in children with spinal muscular atrophy regardless of SMA type, abnormal spinal anatomy and complex spinal instrumentation.
Source: Pediatric Radiology - Category: Radiology Source Type: research